Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.48291 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.36859 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.3703 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.25245 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.3064 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.55126 | 57 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.51344 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.35513 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.32851 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.32378 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.37838 | 55 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.2949 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.38921 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.37046 | 55 |